Why First Wave BioPharma Shares Are Skyrocketing Today

First Wave BioPharma, Inc. FWBI shares are skyrocketing Wednesday after the company entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases, or IBD. The IBD program that treats ulcerative colitis and related conditions was sold to an…#biopharmainc #niclosamide #ibd #firstwave #biopharma #sanofisny #adrulipase #jamessapirstein #firstwavebiopharma #fda
Source: Reuters: Health - Category: Consumer Health News Source Type: news